| Operating Activities |
| Net income |
4.96B |
| Depreciation and amortization |
1.61B |
| Stock-based compensation expense |
190M |
| Cash payments for restructuring charges |
-90M |
| Merger and integration costs |
| Cash payments for merger and integration costs |
| Gain on previously held equity interests in The Pepsi Bottling Group, Inc. (PBG) and PepsiAmericas, Inc. (PAS) |
| Asset write-off |
| Non-cash foreign exchange loss related to Venezuela devaluation |
| Excess tax benefits from share-based payment arrangements |
-115M |
| Pension and retiree medical plan contributions |
-182M |
| Pension and retiree medical plan expenses |
191M |
| Bottling equity income, net of dividends |
| Deferred income taxes and other tax charges and credits |
285M |
| Change in accounts and notes receivable |
-1.3B |
| Change in inventories |
-381M |
| Change in prepaid expenses and other current assets |
-141M |
| Change in accounts payable and other current liabilities |
523M |
| Change in income taxes payable |
813M |
| Other, net |
| Net Cash Provided by Operating Activities |
6.6B |
| Investing Activities |
| Capital spending |
-1.57B |
| Sales of property, plant and equipment |
59M |
| Acquisition of manufacturing and distribution rights from Dr Pepper Snapple Group, Inc. (DPSG) |
| Investment in WBD |
| Other acquisitions and investments in noncontrolled affiliates |
-16M |
| More than three months - purchases |
| More than three months - maturities |
| Three months or less, net |
12M |
| Other investing, net |
9M |
| Net Cash Used For Investing Activities |
-3.03B |
| Proceeds from issuances of long-term debt |
3.36B |
| Payments of long-term debt |
-3.09B |
| More than three months - proceeds |
57M |
| More than three months - payments |
-12M |
| Three months or less, net |
2.02B |
| Cash dividends paid |
-3.14B |
| Share repurchases - common |
-2.08B |
| Share repurchases - preferred |
-3M |
| Proceeds from exercises of stock options |
415M |
| Excess tax benefits from share-based payment arrangements |
115M |
| Acquisition of noncontrolling interests |
| Other financing |
-29M |
| Net Cash (Used for)/Provided by Financing Activities |
-2.39B |
| Effect of exchange rate changes on cash and cash equivalents |
-18M |
| Net (Decrease)/Increase in Cash and Cash Equivalents |
1.16B |
| Cash and Cash Equivalents, Beginning of Year |
9.1B |
| Cash and Cash Equivalents, End of Period |
10.26B |
| Issuance of common stock and equity awards in connection with our acquisitions of PBG and PAS, as reflected in investing and financing activities |
| Operating Activities |
| Merger and integration costs |
| Investing Activities |
| Acquisitions, net of cash and cash equivalents acquired |
| Investing Activities |
| Acquisitions, net of cash and cash equivalents acquired |
